Clinical Trial Update: Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating withdrawal of infliximab in sarcoidosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sarcoidosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING